Please use this identifier to cite or link to this item: https://hdl.handle.net/1/1449
Title: Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Authors: Jagger, Jacqueline ;King, T.;Wood, J.;Woodrow, C.;Snowden, A.;Haines, S.;Crosbie, C.;Houdyk, K.
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: Jul-2018
Source: 5(3):270-284
Journal title: Asia-Pacific Journal of Oncology Nursing
Department: Cancer Services
Abstract: Patients with multiple myeloma (MM) are typically of an advanced age and may have significant co-existing medical conditions. They have often had multiple lines of therapy and as such experience disease-related effects alongside associated treatment toxicities. Daratumumab is a monoclonal antibody approved for the treatment of MM in the relapsed/refractory setting. Clinical studies found that daratumumab showed good tolerability as a monotherapy and in combination with current standard therapies. However, the administration of daratumumab does require specific management considerations. It is administered as an intravenous infusion and infusion-related reactions (IRRs) may occur. Daratumumab also interferes with routine blood transfusion tests, giving false positives for the indirect antiglobulin test. This article highlights key nursing care considerations and practical management aspects to improve the treatment experience of patients receiving daratumumab infusions. Pretreatment aspects, patient education, pre- and post-medication, daratumumab administration, and the management of IRRs are discussed. An IRR management sheet that could be used by nurses and a patient information sheet are located at the end of this article.
URI: https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1449
DOI: 10.4103/apjon.apjon_9_18
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/29963589
ISSN: 2347-5625
Publicaton type: Journal Article
Keywords: Cancer
Drug Therapy
Appears in Collections:Oncology / Cancer

Show full item record

Page view(s)

30
checked on Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.